Technology | Fusion Imaging Software | January 03, 2017

MIM Symphony MRI Fusion Biopsy Software Integrates With BK3000 Ultrasound System

New bkFusion solution will allow more accurate and reliable biopsy results than ultrasound-only transrectal biopsy

MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016

January 3, 2017 —  MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate Fusion Software as a fully integrated software on BK Ultrasound’s premium bk3000 ultrasound system. The global launch of this solution for prostate biopsy, bkFusion, was developed in partnership between the companies.

bkFusion is built on MIM Software’s multi-modality image fusion capabilities. In creating bkFusion, MIM Software leveraged its patented Predictive Fusion technology for MRI prostate fusion during biopsy. Predictive Fusion “reslices” and pre-aligns the MRI images to correspond to the prostate’s orientation during the biopsy and then fuses them to the ultrasound images at the time of biopsy, saving time during the procedure. This advancement in MRI targeting assists the practitioner in achieving a higher prostate cancer detection rate when compared to traditional ultrasound-only transrectal biopsy. Patients will benefit from a more accurate and reliable biopsy when prostate cancer is present.

The bkFusion solution, consisting of the bk3000 ultrasound system along with the E14C4t Prostate Triplane transducer, will provide an MRI Fusion Biopsy System with the smallest footprint in the industry, according to the companies. The bk3000 fits easily into any office space and because bkFusion is completely integrated on the ultrasound system, no additional bulky equipment or setup time is required. The system communicates easily with radiology departments, accessing the MRI images via picture archiving and communication system (PACS) or a secure cloud platform. Alternatively, with the BK Flex Focus ultrasound product line, BK Ultrasound will offer a laptop-based bkFusion application. Both the integrated application and laptop version will provide the same user interface, workflow and reporting.

MIM will continue to develop and distribute its MIM Symphony Dx advanced MRI prostate visualization and analysis software for radiologists. Software features include prostate MRI review, linking, contouring and reporting capabilities. MIM Symphony Dx includes tools for quantitative longitudinal analysis, linking of biopsy results and locations with MR, and sophisticated reporting. MIM Symphony Dx and bkFusion share a common platform and will allow seamless communication either directly, via MIMcloud, or through external drives.

BK Ultrasound will distribute bkFusion for use with its bk3000 and Flex Focus ultrasound systems in the United States. BK Ultrasound has undertaken registration globally and will distribute the solutions through its global network.

For more information: www.mimsoftware.com

Related Content

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Feature | Ultrasound Imaging | July 07, 2020 | By Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater ac
A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane